Decreasing Dialysis Cardiovascular Risk: Daily Versus Longer Treatments

D

Dallas VA Medical Center

Status

Unknown

Conditions

Cardiovascular Disease

Treatments

Procedure: dialysis

Study type

Interventional

Funder types

Other U.S. Federal agency

Identifiers

NCT00925483
#04-050

Details and patient eligibility

About

Given the known increased risk of heart disease in hemodialysis patients, this study aims to evaluate the change in both size and function of the heart by using cardiac magnetic resonance imaging (MRI) in patients undergoing either daily long (4 hours, 6 times weekly), daily short (2 hours 6 times weekly), or alternate day conventional (4 hours, 3 times weekly) and alternate day long (8 hours, 3 times weekly) dialysis for 6 months from randomization. The patients are randomly put in the groups based on predetermined randomization schedule and the cardiologist trained in cardiac MRI readings is blinded to the patient treatment schedule. Given that changes in heart function may be seen with cardiac imaging techniques within 6 months, the expectation is that groups on daily treatment may have better outcome for this parameter as changes in volume and blood pressure may also be affected in a positive way in patients on daily dialysis.

Enrollment

60 estimated patients

Sex

All

Ages

21+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

End stage renal disease patients on hemodialysis

Exclusion criteria

  • Weight > 350 lbs
  • Known poor dialysis and or treatment compliance
  • Unable to come for daily treatments if randomization occurs in this group
  • Prognosis less than 6 months
  • Difficulty in tolerating dialysis and possibility of discontinuation of dialysis before 6 months

Trial design

60 participants in 4 patient groups

daily long
Experimental group
Description:
daily long (4 hours, 6 times weekly) dialysis for 6 months
Treatment:
Procedure: dialysis
daily short
Experimental group
Description:
daily short (2 hours 6 times weekly) dialysis for 6 months
Treatment:
Procedure: dialysis
alternate day conventional
Experimental group
Description:
alternate day conventional (4 hours, 3 times weekly) dialysis for 6 months
Treatment:
Procedure: dialysis
alternate day long
Experimental group
Description:
alternate day long (8 hours, 3 times weekly) dialysis for 6 months
Treatment:
Procedure: dialysis

Trial contacts and locations

0

Loading...

Central trial contact

Devasmita C. Dev, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location

Resources

© Copyright 2024 Veeva Systems